Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$19.63 0.10 (0.51%)
2/9/2010 4:00 PM

Endo Pharmaceuticals (ENDP)

CAPS Rating:
*****

A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ENDP

Add Stock to Watchlist

What the Community Thinks

Total Members

421 Outperforms
17 Underperforms
 

All-Stars

178 Outperforms
2 Underperforms
 

Wall Street

14 Outperforms
1 Underperforms
 

Members bullish on ENDP are also bullish on:

Members bearish on ENDP are also bearish on:

Ticker Tags

Pharmaceuticals (149), Defensive (1457), Healthcare (711), Small Cap (1645)
Suggest a tag

Endo Pharmaceuticals At A Glance

Current Price: $19.63
Last Trade Time: 2/9/2010 4:00 PM
Open: $19.72
Previous Close: $19.53
Daily Range: $19.35 - $19.75
52-Week Range: $15.75 - $24.10
Volume: 1,147,369
Market Cap: $2.30B
P/E Ratio: 11.69
Compare Our Special Broker Offers!

Stock Trends

ENDP VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for ENDP

More Headlines...

Top Bull Pitch

Recs

1

Endo Pharmaceuticals (ENDP)

Avatar healthcarevalue (95.43) Submitted: 12/11/09 6:47 AM

Niche market, generic drugs for painkillers, set to increase dramatically with overemphasis on generic drugs in the coming years. Low price/earnings at ~ 11. Relatively lower market cap at 2.31 Billion. Llow long term debt.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Endo Pharmaceuticals (ENDP)

Avatar MNNice (< 20) Submitted: 2/08/09 9:59 AM

ENDP is being sued by Lectec corp for patent infringement of Lectec's transdermal patch technology. On Friday, Feb 6th, Lectec filed a preliminary injunction against the defendants. The motion is very strong. Lectec has two re-examined patents...no re-examined patent has ever been found invalid i...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 58 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (ENDP)

Avatar ZiggyLuckyShadow (81.69) Submitted: 1/19/10 1:54 PM : Outperform Start Price: $20.23 ENDP Score: 3.68

There were 30 items in your list. Here they are in random order:

1 - UEPS CAPS=5 star
2 - ENDP CAPS=5 star
3 - PPD CAPS=2 star
4 - KHD CAPS=5 star
IDCC
CYTK
UTA
IMMU
RAI
ELNK
CHKE
GHM
DLX
UNTD
SNTA
PRIM
VGR
EXBD
EME
SOLR
PDLI
USMO
QCOR
TSRA
RGR
VCLK
CBI
LO
JCOM
CF
Timestamp: 2010-01-19 18:50:26 UTC

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ENDP)

Avatar Relic666 (66.59) Submitted: 1/15/10 10:59 AM : Underperform Start Price: $20.71 ENDP Score: -0.52

Anything dealing with the health industry is bound to suffer during the next year or so. Until this so called health plan gets finalized and pushed through, I don't see much hope right now for any of these guys.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ENDP)

Avatar Momentum21 (92.12) Submitted: 1/11/10 10:28 AM : Outperform Start Price: $20.45 ENDP Score: 2.36

interesting screen, watchlist

http://seekingalpha.com/article/181924-2010-stock-selection-is-free-cash-flow-the-way-to-go?source=yahoo

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ENDP)

Avatar Wh0am1 (40.60) Submitted: 12/30/09 7:53 AM : Outperform Start Price: $20.67 ENDP Score: -0.57

at least 3 >99

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (ENDP)

Avatar healthcarevalue (95.43) Submitted: 12/11/09 6:47 AM : Outperform Start Price: $19.72 ENDP Score: 3.04

Niche market, generic drugs for painkillers, set to increase dramatically with overemphasis on generic drugs in the coming years. Low price/earnings at ~ 11. Relatively lower market cap at 2.31 Billion. Llow long term debt.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 58 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 15 of 15  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJefferies 82.08 10/03/09 Outperform NS $22.11-11.22%+5.10%-16.31
TrackPiperJaff 85.79 07/31/09 Outperform NS $21.56-8.95%+9.21%-18.16
TrackCitigroup 85.92 07/20/09 Outperform NS $18.35+6.98%+13.78%-6.81
TrackTWeisel < 20 06/02/09 Outperform NS $16.55+18.61%+14.77%+3.84
TrackCarisandCo 86.28 03/16/09 Outperform NS $17.66+11.16%+41.79%-30.63
TrackIcahn 32.10 02/24/09 Outperform 5Y $20.61-4.75%+44.93%-49.69 Toggle the visibility of 60-Second Pitch and replies
TrackJimCramer < 20 01/08/09 Underperform 3W $21.70-9.54%+19.85%+29.39
TrackSoleil 93.91 12/11/08 Outperform NS $22.74-13.68%+22.85%-36.52
TrackRBCCapMkts 86.33 10/31/08 Outperform NS $18.41+6.63%+15.57%-8.95
TrackStanfordRes 85.54 09/25/08 Outperform NS $20.60-4.71%-7.95%+3.24
TrackUBS 87.99 09/16/08 Outperform NS $21.15-7.19%-5.66%-1.53
TrackSusquehanna 74.67 03/27/08 Outperform NS $24.35-19.38%-16.96%-2.42
TrackPacificGrow 89.01 01/24/08 Outperform NS $24.84-20.97%-16.49%-4.48
TrackLehmanBros 85.06 01/10/07 Outperform NS $29.12-32.59%-19.04%-13.55
TrackBroadpoint.AmTech 76.97 12/08/06 Outperform NS $27.99-29.87%-19.35%-10.52

Results 1 - 15 of 15  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 765ms